Apple Inc. acquires VR startup Spaces to offer AR and VR solutions
By Nikita Chaurasia  Date: 2020-08-25

Apple Inc. acquires VR startup Spaces to offer AR and VR solutions

In a recent turn of events, technology giant Apple Inc has acquired startup named Spaces, which is known for expertise in virtual reality technologies (VR).

For the record, Spaces was launched in 2016 by DreamWorks Animation veterans. Since then, the company has been developing VR products including Zoom application, which has gained a lot of limelight lately. It enabled the users to hold video conferencing equipped with virtual reality using animated avatars.

As per the reports, Spaces ceased all its services the previous week without any prior notification and announced on their website that the company is headed in a new direction, further thanking the users and partners.

As per trusted sources, it is not confirmed that the team at Spaces will join any project at Apple that is associated with VR, although rumors suggest that Apple is planning to come up with AR and VR headsets in 2021 and 2022.

If reports are to be believed the headset will feature “cinematic speaker system,” and high-resolution displays which will make it difficult for the user to spot the difference between virtual reality experience provided by the headset and reality. Apple has an aim to become a leading company in the " crossover reality’ and to dominate the entertainment industry, cites sources.

According to the reports, Apple continues to make investment in its ARKit and in new features like the LiDAR scanner in the latest iPad Pro 2020, it’s fair to expect that all of these technologies will be deployed with a new product which will offer advanced augmented and virtual reality capabilities.

Reportedly, both Apple and Spaces did not immediately respond to the request to comment on the acquisition. The financial details of the deal have also not been disclosed yet.

Source credits-

https://9to5mac.com/2020/08/24/apple-reportedly-acquires-vr-startup-spaces/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...